Short term WHO advised multiple drug treatment of paucibacillary patients.
D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use; D014944:World Health Organization
D007917:Leprostatic Agents; D003622:Dapsone; D012293:Rifampin